Want to see IN:GOCLCORP full AI Analyst Report?
GOCL Corporation Limited (GOCLCORP) AI Stock Analysis
GOCL Corporation Limited
(NSE:GOCLCORP)
Mixed financial performance is the largest factor, with balance sheet gains countered by revenue and cash flow volatility. Attractive low P/E valuation and positive technical momentum provide support.
GOCL Corporation Limited (GOCLCORP) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 17.50B
- Dividend Yield
- 9.71%
- Average Volume (3M)
- 19.40K
- Price to Earnings (P/E)
- 4.2
- Beta (1Y)
- 1.46
- Revenue Growth
- -95.58%
- EPS Growth
- -72.91%
- Country
- India
- Employees
- 218
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
GOCL Corporation Limited Business Overview & Revenue Model
Company Description
GOCL Corporation Limited, established in 1961 and headquartered in Hyderabad, India, is a diversified enterprise with operations spanning India and international markets. The company primarily operates across three key segments: energetics, explosive...
GOCL Corporation Limited Financial Statement Overview
Summary
Mixed results: solid balance sheet (75) with equity growth and near-zero debt provides stability, but offset by volatile income statement (45) and weak cash flow (30) with frequent negatives.
Income Statement
45NeutralBalance Sheet
75PositiveCash Flow
30Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.42M | 97.63M | 5.55B | 6.10B | 9.21B | 4.98B |
| Gross Profit | -16.88M | 84.13M | 181.97M | 962.68M | 1.88B | 517.47M |
| EBITDA | 363.32M | 4.01B | 2.73B | 2.14B | 4.58B | 2.56B |
| Net Income | 3.66B | 15.22B | 1.57B | 482.53M | 2.11B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 37.52B | 35.55B | 31.09B | 29.00B | 35.04B | 32.43B |
| Cash, Cash Equivalents and Short-Term Investments | 2.60B | 939.61M | 998.49M | 845.75M | 1.03B | 475.41M |
| Total Debt | 0 | 6.15M | 11.15B | 11.88B | 17.67B | 15.95B |
| Total Liabilities | 6.81B | 4.12B | 15.32B | 14.81B | 20.95B | 20.92B |
| Stockholders Equity | 30.71B | 31.43B | 15.76B | 14.19B | 14.10B | 11.52B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.12B | 9.30M | 244.13M | -961.54M | -726.28M |
| Operating Cash Flow | 0 | 1.33B | 156.72M | 400.03M | -766.37M | -617.13M |
| Investing Cash Flow | 0 | 8.64B | 2.22B | 7.34B | 1.73B | -3.22B |
| Financing Cash Flow | 0 | -9.94B | -2.30B | -8.00B | -898.46M | 3.87B |
GOCL Corporation Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GOCLCORP, the sentiment is Negative. The current price of 308.65 is below the 20-day moving average (MA) of 345.96, below the 50-day MA of 371.03, and below the 200-day MA of 323.06, indicating a bearish trend. The MACD of -16.78 indicates Positive momentum. The RSI at 30.13 is Neutral, neither overbought nor oversold. The STOCH value of 8.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GOCLCORP.
GOCL Corporation Limited Peers Comparison
Overall Rating
IN:KIRIINDUS77Outperform
IN:ROSSARI65Neutral
IN:GOCLCORP65Neutral
IN:BALAMINES57.5Neutral
IN:TATVA55Neutral
IN:CAMLINFINE30Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | INR 35.17B | 0.56 | ― | ― | 10.71% | 2756.39% | |
| 65Neutral | INR 22.12B | 14.48 | ― | 0.13% | 19.76% | 11.74% | |
| 65Neutral | INR 15.30B | 4.17 | ― | 9.71% | -95.58% | -72.91% | |
| 58Neutral | INR 57.16B | 27.90 | ― | 0.63% | 11.08% | 34.10% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 38.49B | 61.11 | ― | 0.12% | 49.69% | 254.75% | |
| 30Underperform | INR 16.15B | 323.46 | ― | ― | 8.40% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:GOCLCORP | GOCL Corporation Limited | 308.65 | -19.84 | -6.04% | |
| IN:BALAMINES | Balaji Amines Limited | 1764.15 | 365.68 | 26.15% | |
| IN:CAMLINFINE | Camlin Fine Sciences Limited | 84.05 | -112.35 | -57.20% | |
| IN:KIRIINDUS | Kiri Industries Limited | 539.70 | 0.75 | 0.14% | |
| IN:ROSSARI | Rossari Biotech Ltd | 399.25 | -249.87 | -38.49% | |
| IN:TATVA | Tatva Chintan Pharma Chem Limited | 1645.45 | 122.83 | 8.07% |
GOCL Corporation Limited Corporate Events
GOCL Board Clears Q2 FY27 Results and Advances Hinduja Power Merger Process
GOCL Corporation Limited’s board has approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The results have undergone a limited review by Haribhakti & Co. LLP, which repo...
GOCL Board Clears Q2 Results, Advances NCLT-Driven Merger with HNPCL
GOCL Corporation Limited’s board has approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, following a limited review by Haribhakti & Co. LLP. The auditor reported no ma...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 08, 2026